A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

With the growing popularity of weight loss medications, many people are turning to prescription options to help them achieve their health goals. Medications like Ozempic, Mounjaro, and Wegovy are ...

The molecules found in Ozempic and Mounjaro could be the secret to curing Alzheimer’s and heart disease, explains ...

Obesity is driving up rates of type 2 diabetes, hypertension, heart disease, fatty liver, sleep apnoea, and even cancers. A ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

A new drug promises to be just as effective as Ozempic — but is taken as a daily ... which have become popular for their dual effectiveness in helping with weight loss and treating diabetes.

Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...

Kristen Gryskevich, 51, found weight to be a struggle throughout her life, but when she gave birth to her two boys in 2001 ...

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

The molecules found in Ozempic and Mounjaro could be the secret ... “It's triple action instead of dual action, so they work on three mechanisms to improve insulin and glucose sensitivity ...